KY Biotechnology & Medical Research

Silexion Therapeutics Corp (SLXN)

Track

Track

Silexion Therapeutics Corp recorded one insider sale on March 26, 2026, when CSO and CDO Shirvan Mitchell disposed of 22,818 shares valued at approximately 31,032 dollars. No further transactions have been reported by company leadership within the last three months, indicating a period of inactivity regarding equity movements by corporate officers.
Ticker: SLXN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Silexion Therapeutics Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.4
Shirvan Mitchell CSO and CDO Officer
Transaction date
Sale
Price
101.67
Quantity 99,778 +15.9%
Value US$3,287,918
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-30 2026-03-26 S Sale
3.4
Shirvan Mitchell

CSO and CDO

Officer
99,778 +15.9%
101.67
US$3,287,918 		99,778 +15.9% 101.67 US$3,287,918
Explore more

More insider trading research around Silexion Therapeutics Corp

More insider trades in KY
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity